[Seite 114↓]

Literatur

[1] Sans, S.; Kesteloot, H. und Kromhout, D. (1997): The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe, Eur Heart J 18 (12): 1231-1248.

[2] Lowel, H.; Lewis, M. und Hormann, A. (1991): Prognostic significance of prehospital phase in acute myocardial infarct. Results of the Augsburg Myocardial Infarct Registry, 1985-1988, Dtsch Med Wochenschr 116 (19): 729-733.

[3] Assessment of the Safety and Efficacy of a New Thrombolytic Investigators (1999): Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial., Lancet 354 (9180): 716-722.

[4] WHO (1979): Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature, Circulation 59 (3): 607-609.

[5] WHO (1959): Hypertension and coronary heart disease: classification and criteria for epidemiological studies., WHO Tech Support Ser 168, Seite 3-28.

[6] Braunwald, E. (1989): Unstable angina. A classification, Circulation 80 (2): 410-414.

[7] Hamm, C. W. und Braunwald, E. (2000): A classification of unstable angina revisited, Circulation 102 (1): 118-122.

[8] Möckel, M.; Störk, T. V.; Heller, G. Jr; Röcker, L.; Danne, O.; Darrelmann, K. G.; Eichstädt, H. und Frei, U. (1998): Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short- and long-term cardiovascular events, Eur Heart J 19 (12): 1802-1807.

[9] Thygesen, K. (1998): Do new biochemical markers of myocardial damage change the concept of unstable angina pectoris?, Eur Heart J 19 (12): 1749-1750.

[10] Braunwald, E.; Jones, R. H.; Mark, D. B.; Brown, J.; Brown, L.; Cheitlin, M. D.; Concannon, C. A.; Cowan, M.; Edwards, C. und Fuster, V. (1994): Diagnosing and managing unstable angina. Agency for Health Care Policy and Research, Circulation 90 (1): 613-622.


[Seite 115↓]

[11] Braunwald, E.; Califf, R. M.; Cannon, C. P.; Fox, K. A.; Fuster, V.; Gibler, W. B.; Harrington, R. A.; King, S. B.; Kleiman, N. S.; Theroux, P.; Topol, E. J.; Van de Werf, F.; White, H. D. und Willerson, J. T. (2000): Redefining medical treatment in the management of unstable angina, Am J Med 108 (1): 41-53.

[12] The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (2000): Myocardial infarction redefined - A consensus document of the joint european society of Cardiology/American college of cardiology committee for the redefinition of myocardial infarction, Eur Heart J 21 (18): 1502-1513.

[13] Jaffe, A. S.; Ravkilde, J.; Roberts, R.; Naslund, U.; Apple, F. S.; Galvani, M. und Katus, H. (2000): It's time for a change to a troponin standard, Circulation 102 (11): 1216-1220.

[14] Sobel, B. E. und LeWinter, M. M. (2000): Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: a recipe for confusion, J Am Coll Cardiol 35 (5): 1355-1358.

[15] Möckel, M.; Schindler, R.; Knorr, L.; Müller, C.; Heller, G. Jr; Störk, T. V. und Frei, U. (1999): Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis, Nephrol Dial Transplant 14 (6): 1489-1495.

[16] Wu, A. H. und Jialal, I. (2000): How specific is cardiac troponin?, Am J Clin Pathol 114 (4): 509-511.

[17] Wu, A. H. und Ford, L. (1999): Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis?, Clin Chim Acta 284 (2): 161-174.

[18] Quinones, M. A. (1997): Risk stratification after myocardial infarction. Clinical science versus practice behavior, Circulation 95 (6): 1352-1354.


[Seite 116↓]

[19] Killip, T. und Kimball, J. T. (1967): Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients, Am J Cardiol 20 (4): 457-464.

[20] Becker, R. C.; Burns, M.; Gore, J. M.; Spencer, F. A.; Ball, S. P.; French, W.; Lambrew, C.; Bowlby, L.; Hilbe, J. und Rogers, W. J. (1998): Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants, Am Heart J 135 (5 Pt 1): 786-796.

[21] Goldman, L.; Cook, E. F.; Johnson, P. A.; Brand, D. A.; Rouan, G. W. und Lee, T. H. (1996): Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain, N Engl J Med 334 (23): 1498-1504.

[22] Jacobs, D. R. Jr; Kroenke, C.; Crow, R.; Deshpande, M.; Gu, D. F.; Gatewood, L. und Blackburn, H. (1999): PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey, Circulation 100 (6): 599-607.

[23] Lee, T. H.; Rouan, G. W.; Weisberg, M. C.; Brand, D. A.; Acampora, D.; Stasiulewicz, C.; Walshon, J.; Terranova, G.; Gottlieb, L. und Goldstein-Wayne, B. (1987): Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room, Am J Cardiol 60 (4): 219-224.

[24] McCarthy, B. D.; Beshansky, J. R.; D'Agostino, R. B. und Selker, H. P. (1993): Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study [see comments], Ann Emerg Med 22 (3): 579-582.

[25] Zimmerman, J.; Fromm, R.; Meyer, D.; Boudreaux, A.; Wun, C. C.; Smalling, R.; Davis, B.; Habib, G. und Roberts, R. (1999): Diagnostic marker cooperative study for the diagnosis of myocardial infarction, Circulation 99 (13): 1671-1677.


[Seite 117↓]

[26] Katus, H. A.; Looser, S.; Hallermayer, K.; Remppis, A.; Scheffold, T.; Borgya, A.; Essig, U. und Geuss, U. (1992): Development and in vitro characterization of a new immunoassay of cardiac troponin T, Clin Chem 38 (3): 386-393.

[27] Katus, H. A.; Remppis, A.; Neumann, F. J.; Scheffold, T.; Diederich, K. W.; Vinar, G.; Noe, A.; Matern, G. und Kuebler, W. (1991): Diagnostic efficiency of troponin T measurements in acute myocardial infarction, Circulation 83 (3): 902-912.

[28] Katus, H. A.; Remppis, A.; Scheffold, T.; Diederich, K. W. und Kuebler, W. (1991): Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction, Am J Cardiol 67 (16): 1360-1367.

[29] Hamm, C. W.; Ravkilde, J.; Gerhardt, W.; Jorgensen, P.; Peheim, E.; Ljungdahl, L.; Goldmann, B. und Katus, H. A. (1992): The prognostic value of serum troponin T in unstable angina, N Engl J Med 327 (3): 146-150.

[30] Ohman, E. M.; Armstrong, P. W.; Christenson, R. H.; Granger, C. B.; Katus, H. A.; Hamm, C. W.; O'Hanesian, M. A.; Wagner, G. S.; Kleiman, N. S.; Harrell-FE, Jr; Califf, R. M. und Topol, E. J. (1996): Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators, N Engl J Med 335 (18): 1333-1341.

[31] Newby, L. K.; Christenson, R. H.; Ohman, E. M.; Armstrong, P. W.; Thompson, T. D.; Lee, K. L.; Hamm, C. W.; Katus, H. A.; Cianciolo, C.; Granger, C. B.; Topol, E. J. und Califf, R. M. (1998): Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators, Circulation 98 (18): 1853-1859.

[32] Antman, E. M.; Tanasijevic, M. J.; Thompson, B.; Schactman, M.; McCabe, C. H.; Cannon, C. P.; Fischer, G. A.; Fung, A. Y.; Thompson, C.; Wybenga, D. und Braunwald, E. (1996): Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes, N Engl J Med 335 (18): 1342-1349.


[Seite 118↓]

[33] Lüscher, M. S.; Thygesen, K.; Ravkilde, J. und Heickendorff, L. (1997): Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia, Circulation 96 (8): 2578-2585.

[34] Wu, A. H. (1998): Analytical and clinical evaluation of new diagnostic tests for myocardial damage, Clin Chim Acta 272 (1): 11-21.

[35] Möckel, M.; Heller, G. Jr; Berg, K.; Klefisch, F.; Danne, O.; Müller, C.; Störk, T. V.; Frei, U. und Wu, A. H. (2000): The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes, Clin Chim Acta 293 (1-2): 139-155.

[36] Gerhardt, W.; Katus, H.; Ravkilde, J.; Hamm, C.; Jorgensen, P. J.; Peheim, E.; Ljungdahl, L. und Lofdahl, P. (1991): S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB, Clin Chem 37 (8): 1405-1411.

[37] Wu, A. H.; Apple, F. S.; Gibler, W. B.; Jesse, R. L.; Warshaw, M. M. und Valdes, R. Jr (1999): National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases, Clin Chem 45 (7): 1104-1121.

[38] Katrukha, A. G.; Bereznikova, A. V.; Esakova, T. V.; Pettersson, K.; Lovgren, T.; Severina, M. E.; Pulkki, K.; Vuopio-Pulkki, L. M. und Gusev, N. B. (1997): Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex, Clin Chem 43 (8 Pt 1): 1379-1385.

[39] Wu, A. H.; Feng, Y. J.; Moore, R.; Apple, F. S.; McPherson, P. H.; Buechler, K. F. und Bodor, G. (1998): Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization, Clin Chem 44 (6 Pt 1): 1198-1208.

[40] Katrukha, A. G.; Bereznikova, A. V.; Filatov, V. L.; Esakova, T. V.; Kolosova, O. V.; Pettersson, K.; Lovgren, T.; Bulargina, T. V.; Trifonov, I. R.; Gratsiansky, N. A.; Pulkki, K.; Voipio-Pulkki, L. M. und Gusev, N. B. (1998): Degradation of cardiac troponin I: implication for reliable immunodetection, Clin Chem 44 (12): 2433-2440.


[Seite 119↓]

[41] Labugger, R.; Organ, L.; Collier, C.; Atar, D. und Van Eyk, J. E. (2000): Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction, Circulation 102 (11): 1221-1226.

[42] Antman, E. M.; Tanasijevic, M. J.; Thompson, B.; Schactman, M.; McCabe, C. H.; Cannon, C. P.; Fischer, G. A.; Fung, A. Y.; Thompson, C.; Wybenga, D. und Braunwald, E. (1996): Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes [see comments], N Engl J Med 335 [18], Seite 1342-1349.

[43] Stubbs, P.; Collinson, P.; Moseley, D.; Greenwood, T. und Noble, M. (1996): Prognostic significance of admission troponin T concentrations in patients with myocardial infarction, Circulation 94 (6): 1291-1297.

[44] Artner-Dworzak, E.; Mair, J.; Seibt, I.; Koller, A.; Haid, C. und Puschendorf, B. (1990): Cardiac troponin T identifies unspecific increases of CKMB after physical exercise, Clin Chem 36 (10): 1853.

[45] Bonetti, A.; Tirelli, F.; Albertini, R.; Monica, C.; Monica, M. und Tredici, G. (1996): Serum cardiac troponin T after repeated endurance exercise events, Int J Sports Med 17 (4): 259-262.

[46] Davila-Roman V.G.; Guest, T. M.; Tuteur, P. G.; Rowe, W. J.; Ladenson, J. H. und Jaffe, A. S. (1997): Transient right but not left ventricular dysfunction after strenuous exercise at high altitude, J Am Coll Cardiol 30 (2): 468-473.

[47] Denvir, M. A.; Galloway, P. J.; Meighan, A. S.; Blyth, M.; Alexander, C.; Fleming, C. und Frame, F. (1999): Changes in skeletal and cardiac muscle enzymes during the Scottish Coast to Coast Triathlon, Scott Med J 44 (2): 49-51.

[48] Koller, A.; Mair, J.; Schobersberger, W.; Wohlfarter, T.; Haid, C.; Mayr, M.; Villiger, B.; Frey, W. und Puschendorf, B. (1998): Effects of prolonged strenuous endurance exercise on plasma myosin heavy chain fragments and other muscular proteins. Cycling vs running, J Sports Med Phys Fitness 38 (1): 10-17.


[Seite 120↓]

[49] Laslett, L.; Eisenbud, E. und Lind, R. (1996): Evidence of myocardial injury during prolonged strenuous exercise, Am J Cardiol 78 (4): 488-490.

[50] Lucia, A.; Serratosa, L.; Saborido, A.; Pardo, J.; Boraita, A.; Moran, M.; Bandres, F.; Megias, A. und Chicharro, J. L. (1999): Short-term effects of marathon running: no evidence of cardiac dysfunction, Med Sci Sports Exerc 31 (10): 1414-1421.

[51] Mair, J.; Genser, N.; Morandell, D.; Maier, J.; Mair, P.; Lechleitner, P.; Calzolari, C.; Larue, C.; Ambach, E.; Dienstl, F.; Pau, B. und Puschendorf, B. (1996): Cardiac troponin I in the diagnosis of myocardial injury and infarction, Clin Chim Acta 245 (1): 19-38.

[52] Mair, J.; Schobersberger, W.; Koller, A.; Bialk, P.; Villiger, B.; Frey, W. und Puschendorf, B. (1997): Risk for exercise-induced myocardial injury for athletes performing prolonged strenuous endurance exercise, Am J Cardiol 80 (4): 543-544.

[53] Mair, J.; Wohlfarter, T.; Koller, A.; Mayr, M.; Artner-Dworzak, E. und Puschendorf, B. (1992): Serum cardiac troponin T after extraordinary endurance exercise, Lancet 340 (8826): 1048.

[54] Rifai, N.; Douglas, P. S.; O'Toole, M.; Rimm, E. und Ginsburg, G. S. (1999): Cardiac troponin T and I, echocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon, Am J Cardiol 83 (7): 1085-1089.

[55] Siegel, A. J.; Sholar, M.; Yang, J.; Dhanak, E. und Lewandrowski, K. B. (1997): Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned?, Cardiology 88 (6): 487-491.

[56] Willich, S. N.; Lewis, M.; Lowel, H.; Arntz, H. R.; Schubert, F. und Schroder, R. (1993): Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group [see comments], N.Engl.J.Med. 329 (23): 1684-1690.


[Seite 121↓]

[57] Mittleman, M. A.; Maclure, M.; Tofler, G. H.; Sherwood, J. B.; Goldberg, R. J. und Muller, J. E. (1993): Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators, N Engl J Med 329 (23): 1677-1683.

[58] Curfman, G. D. (1993): Is exercise beneficial--or hazardous--to your heart?, N Engl J Med 329 (23): 1730-1731.

[59] Curfman, G. D. (1993): The health benefits of exercise. A critical reappraisal [editorial; comment], N.Engl.J.Med. 328 (8): 574-576.

[60] Wheeler, D. C. (1996): Cardiovascular disease in patients with chronic renal failure, Lancet 348 (9043): 1673-1674.

[61] Jaffe, A. S.; Ritter, C.; Meltzer, V.; Harter, H. und Roberts, R. (1984): Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure, J Lab Clin Med 104 (2): 193-202.

[62] Katus, H. A.; Haller, C.; Muller, Bardorff M.; Scheffold, T. und Remppis, A. (1995): Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis, Clin Chem 41 (8 Pt 1): 1201-1203.

[63] Li, D.; Jialal, I. und Keffer, J. (1996): Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure, Clin Chem 42 (1): 114-115.

[64] Li, D.; Keffer, J.; Corry, K.; Vazquez, M. und Jialal, I. (1995): Nonspecific elevation of troponin T levels in patients with chronic renal failure, Clin Biochem 28 (4): 474-477.

[65] Collinson, P. O.; Stubbs, P. J. und Rosalki, S. B. (1995): Cardiac troponin T in renal disease, Clin Chem 41 (11): 1671-1673.

[66] Hafner, G.; Thome, Kromer B.; Schaube, J.; Kupferwasser, I.; Ehrenthal, W.; Cummins, P.; Prellwitz, W. und Michel, G. (1994): Cardiac troponins in serum in chronic renal failure, Clin Chem 40 (9): 1790-1791.


[Seite 122↓]

[67] Bhayana, V.; Gougoulias, T.; Cohoe, S. und Henderson, A. R. (1995): Discordance between results for serum troponin T and troponin I in renal disease, Clin Chem 41 (2): 312-317.

[68] McLaurin, M. D.; Apple, F. S.; Voss, E. M.; Herzog, C. A. und Sharkey, S. W. (1997): Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle, Clin Chem 43 (6 Pt 1): 976-982.

[69] Frankel, W. L.; Herold, D. A.; Ziegler, T. W. und Fitzgerald, R. L. (1996): Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure, Am J Clin Pathol 106 (1): 118-123.

[70] Adams, J. E.; Bodor, G. S.; Davila, Roman, V; Delmez, J. A.; Apple, F. S.; Ladenson, J. H. und Jaffe, A. S. (1993): Cardiac troponin I. A marker with high specificity for cardiac injury, Circulation 88 (1): 101-106.

[71] Trinquier, S.; Flecheux, O.; Bullenger, M. und Castex, F. (1995): Highly specific immunoassay for cardiac troponin I assessed in noninfarct patients with chronic renal failure or severe polytrauma, Clin Chem 41 (11): 1675-1676.

[72] Ooi, D. S.; Veinot, J. P.; Wells, G. A. und House, A. A. (1999): Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study, Clin Biochem 32 (8): 647-652.

[73] Collinson, P. O.; Stubbs, P. J. und Morgan, S. H. (1999): Cardiac troponin-I accurately predicts myocardial injury in renal failure, Nephrol Dial Transplant 14 (4): 1030-1031.

[74] Porter, G. A.; Norton, T. und Bennett, W. B. (1998): Troponin T, a predictor of death in chronic haemodialysis patients, Eur Heart J 19 Suppl N, Seite N34-N37.

[75] Feng, Y. J.; Chen, C.; Fallon, J. T.; Lai, T.; Chen, L.; Knibbs, D. R.; Waters, D. D. und Wu, A. H. (1998): Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model, Am J Clin Pathol 110 (1): 70-77.


[Seite 123↓]

[76] Heyndrickx, G. R.; Amano, J.; Kenna, T.; Fallon, J. T.; Patrick, T. A.; Manders, W. T.; Rogers, G. G.; Rosendorff, C. und Vatner, S. F. (1985): Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons, J Am Coll Cardiol 6 (6): 1299-1303.

[77] Gerhardt, W. und Ljungdahl, L. (1998): Troponin T: a sensitive and specific diagnostic and prognostic marker of myocardial damage, Clin Chim Acta 272 (1): 47-57.

[78] Möckel, M.; Gerhardt, W.; Heller, G. Jr; Klefisch, F.; Danne, O.; Maske, J.; Müller, C.; Störk, T.; Frei, U. und Wu, A. H. (2001): Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndrome, Clin Chim Acta 303, Seite 167-179.

[79] Cockcroft, D. W. und Gault, M. H. (1976): Prediction of creatinine clearance from serum creatinine, Nephron 16 (1): 31-41.

[80] Möckel, M.; Scheinert, D.; Potapov, E.; Wellnhofer, E.; Combé, V.; Nasseri, B.; Maier, D.; Meyer, S.; Yankah, C.; Hetzer, R.; Frei, U.; Eckardt und K.-U. (2000): Continuous measurements of renal perfusion in pigs by means of intravascular Doppler, Kidney Int (in press).

[81] Baum, H.; Braun, S.; Gerhardt, W.; Gilson, G.; Hafner, G.; Muller, Bardorff M.; Stein, W.; Klein, G.; Ebert, C.; Hallermayer, K. und Katus, H. A. (1997): Multicenter evaluation of a second-generation assay for cardiac troponin T, Clin.Chem. 43 (10): 1877-1884.

[82] Fagan, G. J. (1997): Entwicklung und Charakterisierung der Troponin-Antikörper für das Opus Immunoassay-System, Hossmann, V. und Thomas, L., Aktuelle Aspekte in Diagnostik und Therapie kardialer Erkrankungen , Seite 21-29, TH-Books Verlagsgesellschaft, Frankfurt.

[83] Lindahl, B.; Venge, P. und Wallentin, L. (1996): Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group, Circulation 93 (9): 1651-1657.


[Seite 124↓]

[84] Hegner, N.; Baum, H.; Eller, T.; Messinger, M.; Möckel, M.; Mühlbayer, D.; Remmlinger H.P.; Störk, T. und Zinsmeyer, J. (1997): Multizentrische Evaluierung von OPUS Troponin I im Vergleich zu Myoglobin und der CK-MB-Konzentration bei kardialen Erkrankungen, Clin Lab 43, Seite 369-382.

[85] Wu, A. H.; Feng, Y. J.; Contois, J. H.; Azar, R. und Waters, D. (1996): Prognostic value of cardiac troponin I in patients with chest pain, Clin Chem 42 (4): 651-652.

[86] Wu, A. H.; Feng, Y. J.; Contois, J. H. und Pervaiz, S. (1996): Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction, Ann Clin Lab Sci 26 (4): 291-300.

[87] Störk, T.; Möckel, M.; Danne, O.; Abraham, K.; Müller, R.; Eichstädt, H. und Frei, U. (1995): Myoglobin beim akuten Myokardinfarkt. Klinische Wertigkeit in der Infarktdiagnostik, Intensivmed 32, Seite 129-137.

[88] Voss, E. M.; Sharkey, S. W.; Gernert, A. E.; Murakami, M. M.; Johnston, R. B.; Hsieh, C. C. und Apple, F. S. (1995): Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles, Arch Pathol Lab Med 119 (9): 799-806.

[89] Henderson, A. R. und Bhayana, V. (1995): A modest proposal for the consistent presentation of ROC plots in Clinical Chemistry, Clin Chem 41 (8 Pt 1): 1205-1206.

[90] Lindahl, B.; Venge, P. und Wallentin, L. (1997): Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group, J Am Coll Cardiol 29 (1): 43-48.

[91] Lopez-Jimenez, F.; Goldman, L.; Sacks, D. B.; Thomas, E. J.; Johnson, P. A.; Cook, E. F. und Lee, T. H. (1997): Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data, J Am Coll Cardiol 29 (6): 1241-1245.

[92] Bakker, A. J.; Koelemay, M. J.; Gorgels, J. P.; van Vlies, B.; Smits, R.; Tijssen, J. G. und Haagen, F. D. (1993): Failure of new biochemical markers to exclude acute myocardial infarction at admission, Lancet 342 (8881): 1220-1222.


[Seite 125↓]

[93] Dati, F.; Panteghini, M.; Apple, F. S.; Christenson, R. H.; Mair, J. und Wu, A. H. (1999): Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays, Scand J Clin Lab Invest Suppl 230, Seite 113-123.

[94] Panteghini, M.; Apple, F. S.; Christenson, R. H.; Dati, F.; Mair, J. und Wu, A. H. (1999): Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes, Scand J Clin Lab Invest Suppl 230, Seite 103-112.

[95] Panteghini, M.; Apple, F. S.; Christenson, R. H.; Dati, F.; Mair, J. und Wu, A. H. (1999): Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry, Clin Chem Lab Med 37 (6): 687-693.

[96] Reimer, K. A. und Jennings, R. B. (1979): The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow, Lab Invest 40 (6): 633-644.

[97] Fredericks, S.; Merton, G. K.; Lerena, M. J.; Heining, P.; Carter, N. D. und Holt, D. W. (2001): Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals, Clin Chim Acta 304 (1-2): 65-74.

[98] Horstick, G.; Heimann, A.; Gotze, O.; Hafner, G.; Berg, O.; Boehmer, P.; Becker, P.; Darius, H.; Rupprecht, H. J.; Loos, M.; Bhakdi, S.; Meyer, J. und Kempski, O. (1997): Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion, Circulation 95 (3): 701-708.

[99] O'Brien, P. J.; Dameron, G. W.; Beck, M. L.; Kang, Y. J.; Erickson, B. K.; Di Battista, T. H.; Miller, K. E.; Jackson, K. N. und Mittelstadt, S. (1997): Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals, Lab Anim Sci 47 (5): 486-495.


[Seite 126↓]

[100] O'Brien, P. J.; Landt, Y. und Ladenson, J. H. (1997): Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay, Clin Chem 43 (12): 2333-2338.

[101] Lindahl, B.; Venge, P. und Wallentin, L. (1995): Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes, Coron Artery Dis 6 (4): 321-328.

[102] Bhayana, V.; Cohoe, S.; Pellar, T. G.; Jablonsky, G. und Henderson, A. R. (1994): Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin T, Clin Biochem 27 (5): 395-406.

[103] Gerhardt, W.; Ljungdahl, L. und Herbert, A. K. (1993): Troponin-T and CK MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, 1992, Clin Biochem 26 (4): 231-240.

[104] Van-Blerk, M.; Maes, V.; Huyghens, L.; Derde, M. P.; Meert, R. und Gorus, F. K. (1992): Analytical and clinical evaluation of creatine kinase MB mass assay by IMx: comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction, Clin Chem 38 (12): 2380-2386.

[105] Hamm, C. W.; Goldmann, B. U.; Heeschen, C.; Kreymann, G.; Berger, J. und Meinertz, T. (1997): Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I, N Engl J Med 337 (23): 1648-1653.

[106] Gerhardt, W. und Ljungdahl, L. (1997): Detection of myocardial damage by serial measurements of cardiac troponin T, CK MBmass, and TROPT rapid test, Cardiovasc Drugs Ther 11 Suppl 1, Seite 227-240.

[107] Bakker, A. J.; Koelemay, M. J.; Gorgels, J. P.; van Vlies, B.; Smits, R.; Tijssen, J. G. und Haagen, F. D. (1994): Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction, Eur Heart J 15 (1): 45-53.


[Seite 127↓]

[108] Gerhardt, W.; Nordin, G. und Ljungdahl, L. (1999): Can troponin T replace CK MBmass as "gold standard" for acute myocardial infarction ("AMI")?, Scand J Clin Lab Invest Suppl 230, Seite 83-89.

[109] Boden, W. E.; O'Rourke, R. A.; Crawford, M. H.; Blaustein, A. S.; Deedwania, P. C.; Zoble, R. G.; Wexler, L. F.; Kleiger, R. E.; Pepine, C. J.; Ferry, D. R.; Chow, B. K. und Lavori, P. W. (1998): Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators, N Engl J Med 338 (25): 1785-1792.

[110] Lindahl, B.; Andren, B.; Ohlsson, J.; Venge, P. und Wallentin, L. (1997): Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group, Am J Cardiol 80 (5A): 40E-44E.

[111] Mair, J.; Artner, Dworzak E.; Lechleitner, P.; Smidt, J.; Wagner, I.; Dienstl, F. und Puschendorf, B. (1991): Cardiac troponin T in diagnosis of acute myocardial infarction, Clin Chem 37 (6): 845-852.

[112] Ellis, A. K. (1991): Serum protein measurements and the diagnosis of acute myocardial infarction, Circulation 83 (3): 1107-1109.

[113] Mair, J.; Smidt, J.; Lechleitner, P.; Dienstl, F. und Puschendorf, B. (1995): Rapid accurate diagnosis of acute myocardial infarction in patients with non-traumatic chest pain within 1 h of admission, Coron Artery Dis 6 (7): 539-545.

[114] Ravkilde, J.; Horder, M.; Gerhardt, W.; Ljungdahl, L.; Pettersson, T.; Tryding, N.; Moller, B. H.; Hamfelt, A.; Graven, T.; Asberg, A. und et, al (1993): Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction, Scand J Clin Lab Invest 53 (7): 677-685.

[115] Collinson, P. O. und Stubbs, P. J. (1992): The prognostic value of serum troponin T in unstable angina, N Engl J Med 327 (24): 1760-1761.


[Seite 128↓]

[116] Ravkilde, J.; Nissen, H.; Horder, M. und Thygesen, K. (1995): Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients, J Am Coll Cardiol 25 (3): 574-581.

[117] Kelly, D. T. und Wilcox, I. (1994): Determinants of prognosis in unstable angina, Postgrad.Med J 70 Suppl 1, Seite S46-S49.

[118] Miltenburg-van-Zijl, A. J.; Simoons, M. L.; Veerhoek, R. J. und Bossuyt, P. M. (1995): Incidence and follow-up of Braunwald subgroups in unstable angina pectoris, J Am Coll Cardiol 25 (6): 1286-1292.

[119] Wu, A. H. und Feng, Y. J. (1998): Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes, Eur Heart J 19 Suppl N, Seite N25-N29.

[120] Messner, B.; Baum, H.; Fischer, P.; Quasthoff, S. und Neumeier, D. (2000): Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle, Am J Clin Pathol 114 (4): 544-549.

[121] Chen, Y.; Serfass, R. C.; Mackey, Bojack SM; Kelly, K. L.; Titus, J. L. und Apple, F. S. (2000): Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise, J Appl Physiol 88 (5): 1749-1755.

[122] Collinson, P. O.; Chandler, H. A.; Stubbs, P. J.; Moseley, D. S.; Lewis, D. und Simmons, M. D. (1995): Measurement of serum troponin T, creatine kinase MB isoenzyme, and total creatine kinase following arduous physical training, Ann Clin Biochem 32 (Pt 5): 450-453.

[123] Müller-Bardorff, M.; Hallermayer, K.; Schröder, A.; Ebert, C.; Borgya, A.; Gerhardt, W.; Remppis, A.; Zehelein, J. und Katus, H. A. (1997): Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation, Clin Chem 43 (3): 458-466.

[124] Cummins, P.; Young, A.; Auckland, M. L.; Michie, C. A.; Stone, P. C. und Shepstone, B. J. (1987): Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma?, Eur J Clin Invest 17 (4): 317-324.


[Seite 129↓]

[125] Rowe, W. J. (1991): A world record marathon runner with silent ischemia without coronary atherosclerosis, Chest 99 (5): 1306-1308.

[126] Rowe, W. J. (1992): Extraordinary unremitting endurance exercise and permanent injury to normal heart, Lancet 340 (8821): 712-714.

[127] Haskell, W. L.; Sims, C.; Myll, J.; Bortz, W. M.; St Goar, F. G. und Alderman, E. L. (1993): Coronary artery size and dilating capacity in ultradistance runners, Circulation 87 (4): 1076-1082.

[128] Dierkes, J.; Domrose, U.; Westphal, S.; Ambrosch, A.; Bosselmann, H. P.; Neumann, K. H. und Luley, C. (2000): Cardiac troponin T predicts mortality in patients with end-stage renal disease, Circulation 102 (16): 1964-1969.

[129] Stolear, J. C.; Georges, B.; Shita, A. und Verbeelen, D. (1999): The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis, Nephrol Dial Transplant 14 (8): 1961-1967.

[130] Bodor, G. S.; Survant, L.; Voss, E. M.; Smith, S.; Porterfield, D. und Apple, F. S. (1997): Cardiac troponin T composition in normal and regenerating human skeletal muscle, Clin Chem 43 (3): 476-484.

[131] Apple, F. S.; Ricchiuti, V.; Voss, E. M.; Anderson, P. A.; Ney, A. und Odland, M. (1998): Expression of cardiac troponin T isoforms in skeletal muscle of renal disease patients will not cause false-positive serum results by the second generation cardiac troponin T assay, Eur Heart J 19 Suppl N, Seite N30-N33.

[132] Ricchiuti, V. und Apple, F. S. (1999): RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle, Clin Chem 45 (12): 2129-2135.

[133] Ricchiuti, V.; Voss, E. M.; Ney, A.; Odland, M.; Anderson, P. A. und Apple, F. S. (1998): Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim, Clin Chem 44 (9): 1919-1924.


[Seite 130↓]

[134] Martin, G. S.; Becker, B. N. und Schulman, G. (1998): Cardiac troponin-I accurately predicts myocardial injury in renal failure, Nephrol Dial Transplant 13 (7): 1709-1712.

[135] Ingwall, J. S.; Kramer, M. F.; Fifer, M. A.; Lorell, B. H.; Shemin, R.; Grossman, W. und Allen, P. D. (1985): The creatine kinase system in normal and diseased human myocardium, N Engl J Med 313 (17): 1050-1054.

[136] Sackett, D. L. (1989): Rules of evidence and clinical recommendations on the use of antithrombotic agents, Chest 95 (2 Suppl): 2S-4S.

[137] Hamm, C. W.; Heeschen, C.; Goldmann, B. U.; Vahanian, Alec; Adgey, Jennifer; Miguel, Carlos Macaya; Rutsch, Wolfgang; Berger, Juergen; Kootstra, Jille; Simoons, Maarten L und for the c7E3 Fab Antiplatelet in Unstable Refractory Angina (CAPTURE) Study Investigators (1999): Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels, N Engl J Med 340 (21): 1623-1629.

[138] Ishikawa, Y.; Saffitz, J. E.; Mealman, T. L.; Grace, A. M. und Roberts, R. (1997): Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma, Clin Chem 43 (3): 467-475.

[139] Störk, T.; Wu, A. H.; Müller-Bardorff, M.; Gareis, R.; Müller, R.; Katus, H. und Möckel, M. (2000): Diagnostic, and prognostic role of myoglobin in suspected acute coronary syndrome patients, Am J Cardiol 86, Seite 1371-1374.

[140] Wexler, L. F.; Blaustein, A. S.; Lavori, P. W.; Lehmann, K. G.; Wade, M. und Boden, W. E. (2001): Non-Q-wave myocardial infarction following thrombolytic therapy: a comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the Veterans Affairs non-Q-wave Infarction Strategies In-Hospital (VANQWISH) Trial, J Am Coll Cardiol 37 (1): 19-25.


[Seite 131↓]

[141] Chaitman, B. R. und Bitar, S. R. (2001): Is ST segment elevation non-Q-wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy?, J Am Coll Cardiol 37 (1): 26-29.

[142] Wallentin, L.; Lagerqvist, B.; Husted, S.; Kontny, F.; Stahle, E. und Swahn, E. (2000): Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease, Lancet 356 (9223): 9-16.

[143] Morrow, D. A.; Antman, E. M.; Tanasijevic, M.; Rifai, N.; de Lemos, J. A.; McCabe, C. H.; Cannon, C. P. und Braunwald, E. (2000): Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy, J Am Coll Cardiol 36 (6): 1812-1817.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
18.01.2005